Top news of the week: 28.09.2022.
Movers & Shakers: New CEOs at 7 Biopharma Companies
Seven biopharma companies are under new leadership. This week's Movers & Shakers highlights these new chief executive officers who aim to guide their companies into the future.
New Korean Accounting Guidelines Aim For More Flexible Biopharma Practices
<p><span>South Korea moves to lay out clearer accounting guidelines related to R&D costs for pharma and biotech companies, making improvements to earlier official guidance in 2018 in ...
Beyond Biotech podcast 15: Cullinan Oncology, Pleco Therapeutics, TikoMed
This week’s guests are from Cullinan Oncology, Pleco Therapeutics, and TikoMed. We also look at World Cancer Research Day.
Transgene Promises Value Adding Clinical Milestones on R&D Day
During an R&D presentation Tuesday, Transgene executives and oncology experts highlighted promising therapeutic progress in its programs - focusing on its developmental cancer vaccines.
Eli Lilly Becomes Latest Biopharma Sued for Alleged Age Discrimination
The U.S. Equal Employment Opportunity Commission filed a lawsuit Monday against Eli Lilly and Co. alleging the company refused to hire older workers for sales representative positions.
Biotech turns to new and strange viruses to overcome gene therapy’s limitations
“The delivery game isn’t settled yet,” said an investor in gene therapies. “It’s completely unclear who’s going to be the winner.”
GenScript and Gladstone-UCSF Institute of Genomic Immunology Collaborate on Groundbreaking Non-Viral Cell Therapy Study
/PRNewswire/ -- GenScript USA Inc., the world's leading life-science research tools and services provider, is collaborating with researchers at the...
RNAi Developer Sirnaomics Targets Untapped Oncology Indications In China
<p><span>The US- and China-based biotech is expanding three oncology-centered clinical studies of two TGF-1/COX-2-targeted siRNA drug candidates from the US into China.</span></p>